Peter Plomgaard Selected Research

Peter Plomgaard Research Topics

Disease

16	Insulin Resistance 09/2021 - 04/2003
11	Type 2 Diabetes Mellitus (MODY) 10/2022 - 11/2008
10	Obesity 09/2021 - 02/2007
8	Inflammation (Inflammations) 01/2022 - 07/2006
3	Heart Failure 10/2022 - 05/2020
3	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 02/2004
2	Critical Illness (Critically Ill) 10/2015 - 02/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2009 - 06/2005
2	Hyperlipidemias (Hyperlipidemia) 02/2008 - 02/2008
2	Hyperglycemia 07/2007 - 11/2006
1	Hypertrophy 01/2022
1	Biotin deficiency 04/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Neoplasms (Cancer) 01/2018
1	Metabolic Diseases (Metabolic Disease) 10/2017
1	Fibrosis (Cirrhosis) 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Atherosclerosis 03/2012
1	Sarcopenia 01/2011
1	Hypoxia (Hypoxemia) 08/2010
1	Overweight 05/2010
1	Fatigue 06/2009
1	Endotoxemia 02/2008
1	Lipodystrophy 08/2007

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 10/2005
11	Insulin (Novolin)FDA Link 10/2017 - 10/2005
8	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2003
8	Messenger RNA (mRNA)IBA 01/2020 - 02/2007
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 04/2003
6	FollistatinIBA 07/2017 - 01/2011
5	Glucagon (Glukagon)FDA Link 09/2021 - 01/2016
4	fibroblast growth factor 21IBA 09/2021 - 10/2015
3	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2022 - 05/2020
3	Neprilysin (Neutral Endopeptidase)IBA 10/2022 - 05/2020
3	Apolipoproteins MIBA 03/2012 - 08/2009
3	IsotopesIBA 08/2007 - 10/2005
2	Atrial Natriuretic Factor (ANF)IBA 01/2020 - 03/2017
2	MyokinesIBA 01/2018 - 04/2011
2	Pyruvic Acid (Pyruvate)IBA 02/2015 - 11/2006
2	CytokinesIBA 01/2014 - 04/2011
2	Proteins (Proteins, Gene)FDA Link 05/2012 - 08/2010
2	Nonesterified Fatty Acids (NEFA)IBA 02/2008 - 08/2007
2	InterleukinsIBA 02/2007 - 07/2006
2	Interleukin-18 (Interleukin 18)IBA 02/2007 - 07/2006
1	Pancreatic HormonesIBA 10/2022
1	Angiotensin Receptor AntagonistsIBA 10/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 09/2021
1	FructoseIBA 09/2021
1	Biotin (Vitamin H)FDA Link 04/2021
1	Cholecystokinin (Pancreozymin)IBA 05/2020
1	GastrinsIBA 05/2020
1	Calcium-Binding ProteinsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	Circular DNAIBA 01/2018
1	Peptides (Polypeptides)IBA 03/2017
1	acylcarnitineIBA 12/2016
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2016
1	Amino Acids FDA Link 08/2015
1	Oxidoreductases (Dehydrogenase)IBA 02/2015
1	LipopolysaccharidesIBA 02/2015
1	AMP-Activated Protein KinasesIBA 02/2015
1	HexokinaseIBA 05/2012
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 05/2012
1	3-Hydroxyacyl-CoA DehydrogenaseIBA 05/2012
1	Glycogen Synthase (Synthase I)IBA 05/2012
1	oxidized low density lipoproteinIBA 03/2012
1	MyostatinIBA 01/2012
1	Oxygen (Dioxygen)IBA 08/2010
1	HDL LipoproteinsIBA 05/2010
1	Biological ProductsIBA 05/2010
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2010
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 05/2010
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2009
1	LipidsIBA 08/2009
1	AdipokinesIBA 08/2009
1	Adenosine Triphosphate (ATP)IBA 08/2009
1	Interleukin-15 (Interleukin 15)IBA 11/2008
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 08/2008
1	phospholipid emulsion soybean oil (Intralipid)IBA 02/2008
1	EndotoxinsIBA 02/2008
1	acipimoxIBA 08/2007
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2006
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2005
1	Plasminogen Activator Inhibitor 1IBA 06/2005

Therapy/Procedure

2	Bed Rest (Bedrest) 03/2017 - 05/2012
1	Glycemic Control 10/2015
1	Endurance Training 06/2009
1	Therapeutics 02/2008